Anthelos mission is to offer a portfolio of specialized research tools for drug discovery and molecular diagnostics focused on selected therapeutic areas, including the early detection and treatment monitoring for infectious and age-related diseases.

Our plan is to provide reserach laboratories, biotech companies and hospitals with analysis and molecular laboratory testing tools to deliver professional data for drug discovery, clinical trials or medical care.

With the focus on prevention by early diagnosis and the economic value of knowledge in research, development and innovation, we have a strong commitment in providing a service with excellence and quality.

We specialize in the cutting-edge development, production, characterization, and validation of lipid nanoparticle (LNP) systems for next-generation therapeutic delivery.

The Chemical Department of Anthelos develops novel chemical synthetic routes to prepare NCEs. We also perform lead optimization, and focused library synthesis.

Whether you require genome, exome or RNA sequencing, we can support you with our NGS services.

Our services can encompass the entire workflow, including sample preparation, nucleic acid processing, target enrichment, sequencing, and downstream data interpretation.